Last week, both Molex and Novartis announced a scaling down of their Irish operations. Around 800 people will lose their jobs.  Novartis, a pharmaceutical giant, announced 320 people will lose their jobs out of a total of 550 at its Cork campus over the next three years. Some 500 people will lose their jobs at Molex in Shannon, which produces electronic components.  Both companies are foreign-owned. In both cases, the business rationale for closing the plants was pretty clear. Novartis is getting hammered by low-cost rivals across the globe and needs to cut its costs. Following a review, it chose…

Join The Currency

INTRODUCTORY OFFER: Full annual membership for just €200.

Don’t miss out on what is going on with our daily unique stories from our team of skilled journalists and insightful commentators.

Members of The Currency get full access to over 4,000 exclusive interviews, investigations, and analysis, plus over 460 podcasts.

Annual membership is just €200 for the first year, a saving of €100.

Or try The Currency for the first month for a special introductory rate of €5, a saving of €20.

Cancel at any time.

To become a member today click here.